6岁男孩患有多动性多动性多动症 (ADHD) 的初始甲基尼达 (methylphenidate) 给药后增加了对负面记忆的回忆:一个案例报告
Qingqing Xiang1,2, Liling Xu2,3, Yanping Feng2,3
1Child and Adolescent Psychosomatic Medicine Center, Zigong Mental Health Center, Zigong, China.
Neuropsychopharmacology reports
|May 19, 2025
概括
甲基化物是一种常见的ADHD治疗方法,很少导致6岁的孩子回忆起负面的记忆. 这种不寻常的副作用独立地消失了,这表明了适应性反应而不是毒性.
科学领域:
- 神经发育障碍 神经发育障碍
- 儿科医生精神病学 儿科精神病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 注意缺陷/多动障碍 (ADHD) 是一种流行的神经发育障碍,影响儿童和成人.
- 兴奋剂药物,包括甲基,是ADHD的主要治疗方法.
- 虽然已知兴奋剂诱导的精神病或躁狂,但记忆效应的记录较少.
研究的目的:
- 报告一个罕见的病例,在接受甲基酸治疗的儿童中增加了负面记忆回忆.
- 调查这种不良事件的性质及其解决方案.
主要方法:
- 一个被诊断患有ADHD的6岁儿童的案例报告.
- 甲基化延长释放片 (18毫克) 的使用.
- 观察症状的发展和自发的解决.
主要成果:
- 在初始甲基胺剂量后,孩子对负面生活事件的回忆增加.
- 观察到的症状在第二天自发消失.
- 不需要停止药物治疗.
结论:
- 在罕见的情况下,甲基酸盐可以在ADHD儿童中引发负面记忆的回忆.
- 自发的解决方案表明了适应性反应,而不是毒性反应.
- 这一案例凸显了需要在兴奋剂治疗期间仔细监测心理副作用的必要性.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.6K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.8K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
34
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
34
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
88
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
88
